United Kingdom Ulcerative Colitis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031) (undefined)

United Kingdom Ulcerative Colitis Market is Segmented By Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Others), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Dosage Form (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD million) for the above-mentioned segments.

United Kingdom Ulcerative Colitis Market Trends

  • Shift towards biologics from generics: The United Kingdom ulcerative colitis market has witnessed a noticeable shift from traditional generics drugs to novel biologics therapies in recent years. Several biologics drugs that target specific proteins or molecules involved in the inflammation process of ulcerative colitis have become very popular treatment options among patients and physicians. These biologics drugs, such as Humira, Stelara, and Entyvio, have demonstrated high rates of induction and maintenance of remission compared to generic medications in clinical trials. As a result, the prescriptions and sales volumes of these biologics drugs have grown significantly over the forecast period.

Figure 1.  United Kingdom Ulcerative Colitis Market Value (US$ Mn), By Region, 2023

United Kingdom Ulcerative Colitis Market By Region